Cypherpunk Technologies Inc. (CYPH) Stock Score, Valuation & Financial Research

Cypherpunk Technologies Inc. is in the Financial Services sector and Asset Management industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for CYPH

Cypherpunk Technologies Inc. does not currently have a complete Wall Street Score. The stored market price is USD 3.26. These figures are a research snapshot, not a buy or sell recommendation.

What Cypherpunk Technologies Inc. does

Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Cypherpunk Technologies Inc. operates as a privacy technology company that implements a digital asset treasury strategy anchored by Zcash. Additionally, through its subsidiary Leap, the company is engaged in the development of novel therapeutic treatments for patients with cancer.

Products and services

  • The company focuses on privacy-enhancing technologies, specifically within the Zcash ecosystem, and maintains a pharmaceutical pipeline for cancer therapies through its subsidiary, Leap.

Brands and product families

  • Leap — Subsidiary focused on developing novel therapies for patients with cancer. Source

Customer types

Privacy technology users; Patients with cancer.

Business strengths to evaluate

  • Focus on privacy-enhancing technologies and the Zcash ecosystem Source

Business risks and research considerations

  • Risks associated with digital asset treasury strategy and market volatility Source
  • Risks inherent in pharmaceutical drug development and clinical trials Source

Sources: Company research source

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

CYPH financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 3.26
Market capitalization:
347.07M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD -877K
Free cash flow:
USD -43.9M
Cash:
USD 7.62M
Total debt:
USD 38K
EPS:
USD 0.59
P/E ratio:
5.5x

What stands out

  • Free cash flow is USD -43.9M, negative for the stored period.
  • The balance sheet shows USD 7.62M of cash versus USD 38K of total debt, an excess of cash over debt on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Cash exceeds debt by USD 7.59M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for CYPH

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can CYPH fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is CYPH likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for CYPH to reach sustainable profitability?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of CYPH's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research CYPH

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.